Avior Wealth Management LLC Acquires 182 Shares of The Clorox Company (NYSE:CLX)

Avior Wealth Management LLC lifted its stake in shares of The Clorox Company (NYSE:CLX) by 17.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,209 shares of the company’s stock after acquiring an additional 182 shares during the quarter. Avior Wealth Management LLC’s holdings in Clorox were worth $196,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its position in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Clorox during the third quarter valued at about $27,000. Continuum Advisory LLC lifted its position in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Quarry LP grew its holdings in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC acquired a new position in shares of Clorox in the third quarter valued at $48,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.9 %

Shares of CLX opened at $162.35 on Tuesday. The firm has a market capitalization of $20.10 billion, a price-to-earnings ratio of 56.57, a PEG ratio of 2.92 and a beta of 0.42. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The business’s fifty day moving average price is $163.66 and its two-hundred day moving average price is $157.66.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.49 EPS. On average, analysts predict that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.01%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CLX shares. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and boosted their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. DA Davidson boosted their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Finally, StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $156.54.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.